Justin S. Bryans

2.1k citations

45 papers · 1.6k indexed · h-index 20

Organic Chemistry top 5%
- Advanced Synthetic Organic Chemistry 3
- Carbohydrate Chemistry and Synthesis 3
Parasitology top 10%
Cancer Research
- Protease and Inhibitor Mechanisms 3
Public Health, Environmental and Occupational Health top 10%
Molecular Biology
Pharmacology
- Microbial Natural Products and Biosynthesis 5
Physiology
- Pain Mechanisms and Treatments 5
Cellular and Molecular Neuroscience
- Neuroscience and Neuropharmacology Research 5
Toxicology
- Bioactive Compounds and Antitumor Agents 3
Biotechnology
- Marine Sponges and Natural Products 3

Co-authors: David J. Wustrow Simon A. Osborne Catherine Kettleborough Andrew F. Parsons Keith H. Ansell N. Chessum Jonathan M. Large Anton R. Dluzewski
Cited by: Organic Chemistry Parasitology Cancer Research
Journals: Bioorganic & Medicinal Chemistry Letters (11 papers)Tetrahedron Letters (5 papers)Tetrahedron (4 papers)
Partner nations: United Kingdom United States Netherlands

In The Last Decade

Justin S. Bryans

43 papers receiving 1.5k citations

Peers

Countries citing papers authored by Justin S. Bryans

Since Specialization

Citations

This map shows the geographic impact of Justin S. Bryans's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Justin S. Bryans with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Justin S. Bryans more than expected).

Fields of papers citing papers by Justin S. Bryans

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Justin S. Bryans. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Justin S. Bryans. The network helps show where Justin S. Bryans may publish in the future.

Co-authorship network

The 25 scholars most cited alongside Justin S. Bryans, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Justin S. Bryans Line = papers co-authored together Justin S. Bryans links everyone, so they are left out of the graph.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work
1	Abstract 2714: Developing an mRNA encoded therapeutic antibody platform to simplify manufacturing and reduce time to clinic Cancer Research ·Roxana S. Redis,Zainab Abulkhaliq Ahmed,Rachel Pooley,Matthew D. Benson,On Josh,Eva Oswald,William J. Hittinger,S. Ionel,Justin S. Bryans	2024	0
2	Synthesis and structure–activity relationships of a novel series of pyrimidines as potent inhibitors of TBK1/IKKε kinases Bioorganic & Medicinal Chemistry Letters ·Edward G. McIver,Justin S. Bryans,Kristian Birchall,Sayidah Aisyah,Aletta E. Schutte,Stephen J. Lewis,D. A. Moussa,Chhitij Thapa,Mykola Prysiazhniuk,Ahmad M. Kamal,Ty Willke,Michelle Newman,Debra L. Taylor,J. Simon C. Arthur,Kristopher Clark,Philip Cohen	2012	36
3	Effective inhibitors of the essential kinase PknB and their potential as anti-mycobacterial agents Tuberculosis ·Kathryn Lougheed,Simon A. Osborne,Barbara Saxty,David Whalley,Tim Chapman,Nathalie Bouloc,Sayidah Aisyah,Timothy J. Nott,Donald J. Mcmurchy,W Pasini,Catherine Kettleborough,Justin S. Bryans,Debra L. Taylor,Stephen J. Smerdon,Roger S. Buxton	2011	62
4	Discovery of PF-184563, a potent and selective V1a antagonist for the treatment of dysmenorrhoea. The influence of compound flexibility on microsomal stability Bioorganic & Medicinal Chemistry Letters ·Patrick S. Johnson,Thomas Ryckmans,Justin S. Bryans,David M. Beal,Kevin N. Dack,N. Feeder,Anthony Harrison,Mark L. Lewis,Helen J. Mason,James E. Mills,Julie Newman,Yommine Hjalmarsson,Y. B. Chen,Lee R. Roberts,Rachel Russell,Andrea V. Bello,Alan Stobie,Toby J. Underwood,Robyn L. Ward,Irmgard C. Taylor	2011	13
5	Crowd sourcing in drug discovery Nature Reviews Drug Discovery ·Monika Lessl,Justin S. Bryans,Duncan Richards,Khusru Asadullah	2011	41
6	Synthesis and in vivo evaluation of 3-substituted gababutins Bioorganic & Medicinal Chemistry Letters ·David C. Blakemore,Justin S. Bryans,Rahmania Yuniarti,N. Chessum,Mark J. Field,Yundong Ma,邹超贤,Simon A. Osborne,G. Kade	2009	16
7	New anti-tuberculosis agents amongst known drugs Tuberculosis ·Kathryn Lougheed,Debra L. Taylor,Simon A. Osborne,Justin S. Bryans,Roger S. Buxton	2009	67
8	Synthesis and in vivo evaluation of 3,4-disubstituted gababutins Bioorganic & Medicinal Chemistry Letters ·David C. Blakemore,Justin S. Bryans,Rahmania Yuniarti,Mark J. Field,Yundong Ma,邹超贤,Leonard T. Meltzer,Simon A. Osborne,Lisa R. Thompson,G. Kade	2009	13
9	Oxadiazolone bioisosteres of pregabalin and gabapentin Bioorganic & Medicinal Chemistry Letters ·David J. Wustrow,Thomas R. Belliotti,Thomas Capiris,Clare O. Kneen,Justin S. Bryans,Mark J. Field,J.S Neves,Ayman El‐Kattan,黃中華,Jack J. Kinsora,Susan M. Lotarski,Mark G. Vartanian,Charles P. Taylor,Sean D. Donevan,Andrew Thorpe,Jacob B. Schwarz	2008	11
10	Synthesis and in vitro evaluation of imidazopyridazines as novel inhibitors of the malarial kinase PfPK7 Bioorganic & Medicinal Chemistry Letters ·Nathalie Bouloc,Jonathan M. Large,E. Robboy,David Whalley,Keith H. Ansell,E Wisniewska,Justin S. Bryans	2008	31
11	Novel 2-imidazoles as potent, selective and CNS penetrant α1A adrenoceptor partial agonists Bioorganic & Medicinal Chemistry Letters ·Lee R. Roberts,Justin S. Bryans,Kelly Conlon,Gordon McMurray,Alan Stobie,Gavin A. Whitlock	2008	18
12	Subcellular Discharge of a Serine Protease Mediates Release of Invasive Malaria Parasites from Host Erythrocytes Cell ·Sharon Yeoh,Rebecca A. O’Donnell,Konstantinos Koussis,Anton R. Dluzewski,Keith H. Ansell,Simon A. Osborne,Fiona Hackett,Chrislaine Withers‐Martinez,G. H. Mitchell,L. H. Bannister,Justin S. Bryans,Catherine Kettleborough,Michael J. Blackman	2007	260
13	Academia–industry partnerships in drug discovery Expert Opinion on Drug Discovery ·Michael Dalrymple,M. I. Bugrova,Catherine Kettleborough,Justin S. Bryans,Roberto Solari	2006	13
14	Carboxylate bioisosteres of gabapentin Bioorganic & Medicinal Chemistry Letters ·Gitman Gi,Lisa R. Thompson,Clare O. Kneen,Simon A. Osborne,Justin S. Bryans,Thomas Capiris,Nirmala Suman‐Chauhan,David Dooley,Song Si-jun,Mark J. Field,Mark G. Vartanian,Jack J. Kinsora,Susan M. Lotarski,Ayman El‐Kattan,Karen Walters,Cherukury Madhu,Charles P. Taylor,David J. Wustrow,Jacob B. Schwarz	2005	17
15	Stereoselective synthesis of functionalised triol units by SnCl4 promoted allylation of α-benzyloxyaldehydes: crucial role of the stoichiometry of the Lewis acid Tetrahedron ·優子森本,B. Leroy,István E. Markó,Bernard Tinant,Jean‐Paul Declercq,Justin S. Bryans	2004	20
16	Synthesis and biological evaluation of conformationally restricted gabapentin analogues Bioorganic & Medicinal Chemistry Letters ·Jean‐Marie Receveur,Justin S. Bryans,Mark J. Field,Lakhbir Singh,David C. Horwell	1999	24
17	3-Substituted GABA analogs with central nervous system activity: A review Medicinal Research Reviews ·Justin S. Bryans,David J. Wustrow	1999	254
18	An in vitro investigation into conformational aspects of gabapentin Bioorganic & Medicinal Chemistry ·Justin S. Bryans,David C. Horwell,Giles S. Ratcliffe,Jean‐Marie Receveur,John R. Rubin	1999	23
19	ChemInform Abstract: Inhibition of Plasminogen Activator Inhibitor‐1 Activity by Two Diketopiperazines, XR330 and XR334 Produced by Streptomyces sp. ChemInform ·Justin S. Bryans,Peter Charlton,Zaky Faris Maulana,Erma Yuliani,Richard Faint,和宏小林,Ina Shaw,R J Frock	1997	1
20	Inhibition of Plasminogen Activator Inhibitor-1 Activity by Two Diketopiperazines, XR330 and XR334 Produced by Streptomyces sp. The Journal of Antibiotics ·Justin S. Bryans,Peter Charlton,Zaky Faris Maulana,Mark A. Collins,Richard Faint,和宏小林,Ian C. Shaw,R J Frock	1996	50

About Justin S. Bryans

Justin S. Bryans is a scholar working on Toxicology, Organic Chemistry and Cancer Research, having authored 45 papers that have together received 1.6k indexed citations. Recurring topics across this work include Microbial Natural Products and Biosynthesis (5 papers), Pain Mechanisms and Treatments (5 papers), Neuroscience and Neuropharmacology Research (5 papers), Bioactive Compounds and Antitumor Agents (3 papers), Advanced Synthetic Organic Chemistry (3 papers), Marine Sponges and Natural Products (3 papers), Protease and Inhibitor Mechanisms (3 papers) and Carbohydrate Chemistry and Synthesis (3 papers). The work is most often cited by research in Organic Chemistry (504 citations), Parasitology (69 citations) and Cancer Research (135 citations). Justin S. Bryans has collaborated with scholars based in United Kingdom, United States and Netherlands. Frequent co-authors include David J. Wustrow, Simon A. Osborne, Catherine Kettleborough, Andrew F. Parsons, Keith H. Ansell, N. Chessum, Jonathan M. Large, Anton R. Dluzewski, Debra L. Taylor and Sharon Yeoh. Their work appears in journals such as Bioorganic & Medicinal Chemistry Letters, Tetrahedron Letters, Tetrahedron, Tuberculosis and Cancer Research.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact